Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals

INTRODUCTION: Plasma amyloid β (Aβ) peptides have been previously studied as candidate biomarkers to increase recruitment efficiency in secondary prevention clinical trials for Alzheimer's disease. METHODS: Free and total Aβ42/40 plasma ratios (FP42/40 and TP42/40, respectively) were determined...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Alzheimers Dement (Amst)
Main Authors: Fandos, Noelia, Pérez-Grijalba, Virginia, Pesini, Pedro, Olmos, Salvador, Bossa, Matías, Villemagne, Victor L., Doecke, James, Fowler, Christopher, Masters, Colin L., Sarasa, Manuel
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2017
Teme:
Blood-Based Biomarkers
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5602863/
https://ncbi.nlm.nih.gov/pubmed/28948206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2017.07.004
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki